February 08, 2017
Information on ReLive Trial Design and Role of its Data Safety and Monitoring Board
Media
February 08, 2017
Oncopeptides AB (publ) announces a listing of its shares on Nasdaq Stockholm
February 06, 2017
Altimmune to Present at the BIO CEO & Investor Conference
February 06, 2017
Targovax ASA: Invitation to fourth quarter and full year 2016 results presentation Thursday 16 February
February 06, 2017
Q4 2016 General Market Overview
February 02, 2017
Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients
February 02, 2017
Strongbridge Biopharma plc to Participate in the Canaccord Genuity Rare Disease and BioPharma One-on-One Day
January 31, 2017
Neurosurgeons from Germany and U.S.A. report on their clinical experience of using Nexstim NBS system
January 31, 2017
Radiotherapy, immunotherapy and DNA repair inhibitors: a winning combination towards the oncology of the future
January 31, 2017
GenSight Biologics receives FDA Orphan Drug Designation for GS030 in Retinitis Pigmentosa
